Matthew F. Pescosolido

Matthew F. Pescosolido

Auto-generated profile, based on publicly available information

Matthew F. Pescosolido

Brown University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EVEmma W. Viscidi
Emma W. Viscidi
ETElizabeth W. Triche
Elizabeth W. Triche
MPMatthew F. Pescosolido
Matthew F. Pescosolido
RMRebecca L. McLean
Rebecca L. McLean
RJRobert M. Joseph
Robert M. Joseph
EMEric M. Morrow
Eric M. Morrow
To estimate the prevalence of epilepsy in children with Autism Spectrum Disorder (ASD) and to determine the demographic and clinical characteristics of children with ASD and epilepsy in a large patient population. Cross-sectional study using four samples of children with ASD for a total of 5,815 participants with ASD. The prevalence of epilepsy was estimated from a population-based sample. Children with and without epilepsy were compared on demographic and clinical characteristics. Multivariate logistic regression was used to examine the association between demographic and clinical characteristics and epilepsy. The average prevalence of epilepsy in children with ASD 2–17 years was 12.5%; among children aged 13 years and older, 26% had epilepsy. Epilepsy was associated with older age, lower cognitive ability, poorer adaptive and language functioning, a history of developmental regression and more severe ASD symptoms. The association between epilepsy and the majority of these characteristics appears to be driven by the lower IQ of participants with epilepsy. In a multivariate regression model, only age and cognitive ability were independently associated with epilepsy. Children age 10 or older had 2.35 times the odds of being diagnosed with epilepsy (p<.001) and for a one standard deviation increase in IQ, the odds of having epilepsy decreased by 47% (p<.001). This is among the largest studies to date of patients with ASD and co-occurring epilepsy. Based on a representative sample of children with ASD, the average prevalence of epilepsy is approximately 12% and reaches 26% by adolescence. Independent associations were found between epilepsy and older age and lower cognitive ability. Other risk factors, such as poor language and developmental regression, are not associated with epilepsy after controlling for IQ. These findings can help guide prognosis and alert clinicians to patients with ASD who are at increased risk for epilepsy.

1 January 2012 in Research in Autism Spectrum Disorders
Verified
Journal Article
Closed access
TLTodd P. Levine
Todd P. Levine
SSStephen J. Sheinkopf
Stephen J. Sheinkopf
MPMatthew Pescosolido
Matthew Pescosolido
ARAlison Rodino
Alison Rodino
GEGregory Elia
Gregory Elia
BLBarry Lester
Barry Lester

14 July 2014 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
MPMatthew F. Pescosolido
Matthew F. Pescosolido
DSDavid M. Stein
David M. Stein
MSMichael Schmidt
Michael Schmidt
CAChristelle Moufawad El Achkar
Christelle Moufawad El Achkar
MSMark Sabbagh
Mark Sabbagh
EMEric M. Morrow
Eric M. Morrow

1 March 2013 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
DDDaniel P. Dickstein
Daniel P. Dickstein
MPMatthew F. Pescosolido
Matthew F. Pescosolido
BRBrooke L. Reidy
Brooke L. Reidy
TGThania Galvan
Thania Galvan
KKKerri L. Kim
Kerri L. Kim
RBRowland P. Barrett
Rowland P. Barrett

1 July 2015 in Neurotherapeutics
Verified
Journal Article
Open access
PDF file
Ece UzunEce Uzun
Ece Uzun
LSLaura N. Sciarra
Laura N. Sciarra
AMAbbie M. Maguire
Abbie M. Maguire
MPMatthew F. Pescosolido
Matthew F. Pescosolido
LDLaura I. van Dyck
Laura I. van Dyck
EMEric M. Morrow
Eric M. Morrow
Autism spectrum disorder (ASD) is a group of highly genetic neurodevelopmental disorders characterized by language, social, cognitive, and behavioral abnormalities. ASD is a complex disorder with a heterogeneous etiology. The genetic architecture of autism is such that a variety of different rare mutations have been discovered, including rare monogenic conditions that involve autistic symptoms. Also, de novo copy number variants and single nucleotide variants contribute to disease susceptibility. Finally, autosomal recessive loci are contributing to our understanding of inherited factors. We will review the progress that the field has made in the discovery of these rare genetic variants in autism. We argue that mutation discovery of this sort offers an important opportunity to identify neurodevelopmental mechanisms in disease. The hope is that these mechanisms will show some degree of convergence that may be amenable to treatment intervention.

10 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
SLSofia B. Lizarraga
Sofia B. Lizarraga
LMLi Ma
Li Ma
AMAbbie M. Maguire
Abbie M. Maguire
LDLaura I. van Dyck
Laura I. van Dyck
QWQing Wu
Qing Wu
EMEric M. Morrow
Eric M. Morrow
Neurons from patient-derived iPSCs demonstrate mutation-specific responses to potential therapeutic strategies for Christianson syndrome.